Cartesian Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment in USD from Q1 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Cartesian Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2016 to Q1 2024.
  • Cartesian Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $602K, a 363% increase year-over-year.
  • Cartesian Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $206K, a 82.8% decline from 2022.
  • Cartesian Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $1.2M, a 10.7% increase from 2021.
  • Cartesian Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $1.09M, a 33.1% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $602K +$472K +363% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 $130K -$325K -71.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $455K +$430K +1720% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $25K -$110K -81.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $135K +$135K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $0 -$192K -100% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $192K +$134K +231% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $58K -$85K -59.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 $143K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.